Study of Heritable Connective Tissue Disorders
Launched by NATIONAL HUMAN GENOME RESEARCH INSTITUTE (NHGRI) · Nov 3, 1999
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
We will investigate the clinical manifestations and molecular genetic defects of heritable connective tissue disorders, concentrating on the Marfan, Stickler, and Ehlers-Danlos syndromes. Although each of these conditions has been known for many years, the full spectrum of the associated phenotypes continues to be expanded and the genetic etiology of these conditions has not been completely elucidated. In addition, many patients have features overlapping two or more of the described syndromes, precluding unequivocal diagnosis. The goals of this study are to further define and characterize t...
Gender
ALL
Eligibility criteria
- INCLUSION CRITERIA:
- • Individuals and their family members will be offered enrollment if they have a suspected or established diagnosis of Marfan, Stickler, Ehlers-Danlos, or a closely related syndrome.
- Personal or family history of one or more of the following features in a pattern suggestive of a heritable connective tissue disorder:
- • Marfanoid body habitus;
- • Aortic dilatation and/or dissection;
- • Ectopia lentis, detached retina, vitreous degeneration and/or early onset high myopia;
- • Posterior cleft palate; joint laxity and/or dislocation;
- • Premature osteoarthritis;
- • Skin fragility, striae, easy bruisability and/or hyperextensibility;
- • Pectus excavatum or carinatum;
- • Scoliosis, spondylolisthesis, and/or dural ectasia;
- • High frequency sensorineural hearing loss.
- EXCLUSION CRITERIA:
- • Inability to provide informed consent.
About National Human Genome Research Institute (Nhgri)
The National Human Genome Research Institute (NHGRI) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing the field of genomics and its applications in health and medicine. NHGRI sponsors and conducts a wide range of clinical trials aimed at understanding the genetic basis of diseases, developing innovative genomic technologies, and translating genomic research into clinical practice. With a commitment to ethical research and collaboration, NHGRI plays a pivotal role in shaping the future of personalized medicine and improving patient outcomes through genomic discoveries.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials